undefined
EUTM file information

019076096

OeDNA


September 5, 2024

Trademark Summary

The trademark application oeDNA was filed by 4BASEBIO PLC, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on October 9, 2024, and still open for oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemical, biochemical, biological, biotechnological reagents, preparations and substances for laboratory use in the fields of life science, biotechnology and genomics
    2. Diagnostic and laboratory reagents, preparations and substances, for scientific use in the fields of life science, biotechnology and genomics
    3. Enzyme preparations for industrial purposes
    4. Enzymes for industrial purposes
    5. Industrial chemicals
    6. Biochemical catalysts
    7. Diagnostic preparations, other than for medical or veterinary purposes
    8. Biological preparations, other than for medical or veterinary purposes
    9. Proteins for use in recombinant DNA technology [other than for medical use].
  • The mark was filed in class 5 with following description of goods:
    1. Chemicals for use in medical laboratories and/or for medical diagnostic purposes
    2. Therapeutic and diagnostic preparations and reagents for use in medical laboratories and/or for medical diagnostic purposes
    3. Biochemical, biological, biotechnological reagents, preparations and substances for use in medical laboratories and/or for medical diagnostic purposes
    4. Vaccine preparations
    5. Proteins for use in recombinant DNA technology for use in medical laboratories and/or for medical diagnostic purposes.
  • The mark was filed in class 9 with following description of goods:
    1. Scientific and laboratory apparatus, instruments and equipment for measurement, analysis and quantification of chemical, biochemical and biological components for genomic and nucleic acid research
    2. Apparatus, equipment and instruments for the detection and analysis of nucleic acids
    3. Kits containing apparatus, devices, instruments and equipment for measurement, analysis and quantification of chemical, biochemical and biological components for genomic and nucleic acids research
    4. Computer software applications, downloadable
    5. Material testing instruments and machines
    6. Testing apparatus not for medical purposes
    7. Diagnostic apparatus, not for medical purposes
    8. Chemistry apparatus and instruments
    9. DNA chips
    10. Surveying apparatus and instruments
    11. Laboratory bioreactors
    12. Genetic testing apparatus for scientific use
    13. Laboratory apparatus for detecting genetic sequences.
  • The mark was filed in class 42 with following description of goods:
    1. Laboratory research services in the fields of life science, biotechnology and genomics
    2. Scientific research services in the fields of life science, biotechnology and genomics
    3. Biological, biotechnological, chemical and biochemical research, analysis and development services in the fields of life science, biotechnology and genomics
    4. Contract research services in the fields of life science, biotechnology and genomics
    5. Nucleic acids discovery, analysis and research and development services
    6. Nucleic acids and genomics research and development services for drugs and pharmaceutical discovery and research
    7. Nucleic acids production, processing and purification services
    8. Consultancy services relating to nucleic acids and genomics
    9. Research services for nucleic acids for therapeutic or diagnostic use
    10. Purification and production of nucleic acids for therapeutic or diagnostic use
    11. Design and manufacture of synthetic DNA, genes and oligonucleotides for others
    12. Genetic research
    13. Research and development services in the field of genomics
    14. Research and development services relating to vaccines and medicines
    15. A proprietary technology platform containing non-viral nanoparticles.